What’s new in Biomarker Base ? … Biomarker Workspace View

Personalized medicine is an exciting space that is moving and changing quickly.  Staying on top of the changes and identifying parallel opportunities is difficult.  How do you identify what disease areas are complementary to your existing product strategy?  What is...

Metabolic Biomarkers Dominate Companion Diagnostics

We are soon going to release a report describing trends in the development and use of companion diagnostic biomarkers, and a key part of preparing this report was breaking down companion diagnostic biomarkers into relevant groups.  A very clear initial division is...

Tracking Biomarker Trends Still a Big Problem

GenomeWeb published an article today about the connection between BRCA2 and prostate tumors.  As always, a clear connection between a biomarker like BRCA2 and a disease area is good for the future of personalized medicine.  It will allow us to better tailor therapies...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access